← Back to All Filings

Intuitive Surgical Director Gary Guthart Disposes of $9.08M in Stock Under 10b5-1 Plan

Medium SignificanceOctober 26, 2026 at 3:05:34 PM EDT

INTUITIVE SURGICAL INC

$ISRG4CIK: 0001035267

Subscribe to track ISRG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ISRG Insider Filing Alert Reporting Owner: Gary S. Guthart (Director) Company: Intuitive Surgical Inc (ISRG) Transaction: Open market sale of 20,095 shares at an average price of $451.61 per share ($9,075,137 total value). Ownership Type: Indirect (by Trust) Post-Transaction Holdings: 1,204,530 shares (Trust), plus 52,494 shares held across children's trusts. Note: Conducted pursuant to a pre-arranged Rule 10b5-1 trading plan expiring June 15, 2027.

Comprehensive Analysis

Executive Summary

On October 23, 2026, Gary S. Guthart, Director at Intuitive Surgical Inc ($ISRG), completed a sale of 20,095 shares of Common Stock at a volume-weighted average price of $451.6117, generating gross proceeds of approximately $9.08 million. The transaction was reported to the SEC on Form 4 on October 26, 2026.

Transaction Details

  • Security: Common Stock
  • Nature of Transaction: Open market sale (Transaction Code 'S')
  • Shares Sold: 20,095
  • Weighted Average Price: $451.6117 (Individual price ranges spanned from $444.04 to $458.10)
  • Total Transaction Value: $9,075,137.11
  • Ownership Post-Transaction: 1,204,530 shares held indirectly through a Trust, alongside 26,247 shares held in trust for his daughter and 26,247 shares in trust for his son.

Governance and Trading Plan Context

The transaction was executed pursuant to a Rule 10b5-1 trading plan established earlier, with an expiration date of June 15, 2027. Rule 10b5-1 trading plans allow corporate insiders to set up a predetermined schedule for buying or selling shares, shielding them from accusations of insider trading based on non-public material information.

Impact and Holdings Assessment

Despite the significant monetary value of $9.08 million, the disposal represents approximately 1.6% of Dr. Guthart's primary trust holdings. He continues to hold over 1.25 million shares across various family trust accounts, maintaining significant alignment with long-term shareholder value. Because the sale was executed under an established Rule 10b5-1 plan and reflects a modest fraction of his overall holdings, it is rated as having Medium trading significance.

Topics:#ISRG#IntuitiveSurgical#InsiderSelling#StockMarket#MedTech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.